485 related articles for article (PubMed ID: 18597247)
21. Immunization of pups with maternally derived antibodies to canine parvovirus (CPV) using a modified-live variant (CPV-2b).
Pratelli A; Cavalli A; Normanno G; De Palma MG; Pastorelli G; Martella V; Buonavoglia C
J Vet Med B Infect Dis Vet Public Health; 2000 May; 47(4):273-6. PubMed ID: 10861195
[TBL] [Abstract][Full Text] [Related]
22. Antibodies to parvovirus, distemper virus and adenovirus conferred to household dogs using commercial combination vaccines containing Leptospira bacterin.
Taguchi M; Namikawa K; Maruo T; Lynch J; Sahara H
Vet Rec; 2010 Dec; 167(24):931-4. PubMed ID: 21262693
[TBL] [Abstract][Full Text] [Related]
23. Diagnostic Challenges in Canine Parvovirus 2c in Vaccine Failure Cases.
Yip HYE; Peaston A; Woolford L; Khuu SJ; Wallace G; Kumar RS; Patel K; Ahani Azari A; Akbarzadeh M; Sharifian M; Amanollahi R; Jafari Jozani R; Khabiri A; Hemmatzadeh F
Viruses; 2020 Sep; 12(9):. PubMed ID: 32899378
[TBL] [Abstract][Full Text] [Related]
24. Vaccination of dogs with Duramune DAPPi+LC protects against pathogenic canine parvovirus type 2c challenge.
Wilson S; Stirling C; Borowski S; Thomas A; King V; Salt J
Vet Rec; 2013 Jun; 172(25):662. PubMed ID: 23748583
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of the antigenic relationships among canine parvovirus type 2 variants.
Cavalli A; Martella V; Desario C; Camero M; Bellacicco AL; De Palo P; Decaro N; Elia G; Buonavoglia C
Clin Vaccine Immunol; 2008 Mar; 15(3):534-9. PubMed ID: 18160619
[TBL] [Abstract][Full Text] [Related]
26. Early protection of puppies against canine parvovirus: a comparison of two vaccines.
McCaw DL; Tate D; Dubovi EJ; Johnson JC
J Am Anim Hosp Assoc; 1997; 33(3):244-50. PubMed ID: 9138235
[TBL] [Abstract][Full Text] [Related]
27. Are licensed canine parvovirus (CPV2 and CPV2b) vaccines able to elicit protection against CPV2c subtype in puppies?: A systematic review of controlled clinical trials.
Hernández-Blanco B; Catala-López F
Vet Microbiol; 2015 Oct; 180(1-2):1-9. PubMed ID: 26249827
[TBL] [Abstract][Full Text] [Related]
28. Canine parvovirus in vaccinated dogs: a field study.
Miranda C; Thompson G
Vet Rec; 2016 Apr; 178(16):397. PubMed ID: 26960988
[TBL] [Abstract][Full Text] [Related]
29. Genetic analysis of canine parvovirus from dogs in Australia.
Meers J; Kyaw-Tanner M; Bensink Z; Zwijnenberg R
Aust Vet J; 2007 Oct; 85(10):392-6. PubMed ID: 17903125
[TBL] [Abstract][Full Text] [Related]
30. Response of puppies to canine-origin parvovirus vaccines.
Carmichael LE; Pollock RV; Joubert JC
Mod Vet Pract; 1984 Feb; 65(2):99-102. PubMed ID: 6328258
[TBL] [Abstract][Full Text] [Related]
31. Detection of canine parvovirus type 2c by a commercially available in-house rapid test.
Decaro N; Desario C; Beall MJ; Cavalli A; Campolo M; Dimarco AA; Amorisco F; Colaianni ML; Buonavoglia C
Vet J; 2010 Jun; 184(3):373-5. PubMed ID: 19410488
[TBL] [Abstract][Full Text] [Related]
32. Comparative trial of the canine parvovirus, canine distemper virus and canine adenovirus type 2 fractions of two commercially available modified live vaccines.
Bergman JG; Muniz M; Sutton D; Fensome R; Ling F; Paul G
Vet Rec; 2006 Nov; 159(22):733-6. PubMed ID: 17127756
[TBL] [Abstract][Full Text] [Related]
33. Maternally-derived antibodies in pups and protection from canine parvovirus infection.
Decaro N; Campolo M; Desario C; Elia G; Martella V; Lorusso E; Buonavoglia C
Biologicals; 2005 Dec; 33(4):261-7. PubMed ID: 16168665
[TBL] [Abstract][Full Text] [Related]
34. Evolution of canine parvovirus--a need for new vaccines?
Truyen U
Vet Microbiol; 2006 Oct; 117(1):9-13. PubMed ID: 16765539
[TBL] [Abstract][Full Text] [Related]
35. Simple tests for rapid detection of canine parvovirus antigen and canine parvovirus-specific antibodies.
Marulappa SY; Kapil S
Clin Vaccine Immunol; 2009 Jan; 16(1):127-31. PubMed ID: 18987166
[TBL] [Abstract][Full Text] [Related]
36. Are vaccine strain, type or administration protocol risk factors for canine parvovirus vaccine failure?
Altman KD; Kelman M; Ward MP
Vet Microbiol; 2017 Oct; 210():8-16. PubMed ID: 29103701
[TBL] [Abstract][Full Text] [Related]
37. Oral administration of modified live canine parvovirus type 2b induces systemic immune response.
Cavalli A; Desario C; Marinaro M; Losurdo M; Camero M; Decaro N; Catella C; Lanave G; Buonavoglia C
Vaccine; 2020 Jan; 38(2):115-118. PubMed ID: 31628031
[TBL] [Abstract][Full Text] [Related]
38. Molecular characterisation and nucleotide sequence analysis of canine parvovirus strains in vaccines in India.
Nandi S; Anbazhagan R; Kumar M
Vet Ital; 2010; 46(1):69-81. PubMed ID: 20391369
[TBL] [Abstract][Full Text] [Related]
39. Seroconversion of puppies to canine parvovirus and canine distemper virus: a comparison of two combination vaccines.
Coyne MJ
J Am Anim Hosp Assoc; 2000; 36(2):137-42. PubMed ID: 10730624
[TBL] [Abstract][Full Text] [Related]
40. [Case report: effect of maternal antibodies on the vaccination against canine parvovirus].
Schunck B; Truyen U
Tierarztl Prax; 1995 Apr; 23(2):185-6. PubMed ID: 7624862
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]